Airway pressure release ventilation (APRV)
APRV mode · Critical Care / ICU
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
APRV applies a sustained high continuous positive pressure (P-high) with brief timed releases (P-low) to a short expiratory time, allowing spontaneous breathing throughout. It is used as a rescue or open-lung strategy in selected hypoxaemic respiratory failure but lacks proven mortality benefit and carries risk if misapplied.
Red flags
- Worsening hypoxaemia or hypercapnia after 2-4 h
- Hypotension from high mean airway pressure
- Pneumothorax / barotrauma
- Patient apnoea leading to inadequate release ventilation
- Rising CO2 with falling pH
Assessment
Differential diagnosis
- Refractory ARDS
- Atelectasis-prone lung
- Post-operative hypoxaemia
- Trauma lung contusion
- Failure of conventional lung-protective ventilation
Investigations
- ABG and P/F ratio
- Continuous waveform and release-volume monitoring
- Chest imaging
- Haemodynamic assessment / echo for RV
- End-expiratory flow analysis to set T-low
Management
- Confirm patient has some spontaneous respiratory drive and is adequately but not deeply sedated
- Set P-high near the prior plateau pressure, typically 25-30 cmH2O
- Set T-high long, usually 4-6 s, to maximise mean airway pressure and recruitment
- Set P-low to 0 cmH2O (auto-PEEP from short release maintains recruitment)
- Set T-low short, 0.4-0.8 s, titrated so expiratory flow terminates at 50-75% of peak expiratory flow
- Target total release ventilation to maintain acceptable CO2 clearance and pH above 7.20
- Keep spontaneous breathing to augment dependent lung ventilation; avoid deep paralysis if possible
- Monitor for haemodynamic compromise from high mean airway pressure and RV strain
- Reassess oxygenation and compliance; if no improvement in 2-4 h consider reverting or proning
- Wean by stepwise reduction of P-high and lengthening T-high (drop and stretch) toward CPAP
- Avoid APRV in obstructive airways disease and significant air-trapping
Drugs & doses
Dexmedetomidine 0.2-1.4 mcg/kg/h IV (preserves respiratory drive)
Propofol 0.3-2 mg/kg/h IV infusion
Fentanyl 0.5-2 mcg/kg/h IV infusion
Disposition
ICU only, with senior intensivist directing mode selection and titration. Have a plan to revert to conventional ventilation if no benefit.
Complications & pitfalls
- Barotrauma
- RV failure from sustained high intrathoracic pressure
- CO2 retention
- Haemodynamic instability
- Air trapping in obstructive disease
Exam pearls
- T-low is set by expiratory flow, not time alone; terminate at 50-75% peak expiratory flow
- APRV relies on spontaneous breathing - deep paralysis defeats its purpose
- Not a proven mortality strategy; reserve for failure of standard lung-protective ventilation
- Contraindicated in asthma/COPD due to air-trapping
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.